{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:01:17Z","timestamp":1753740077334,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Public Ministry of Labor (MPT), Campinas"},{"name":"PRONON"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11060-022-03965-1","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T13:11:16Z","timestamp":1644930676000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study"],"prefix":"10.1007","volume":"157","author":[{"given":"Daniel Antunes","family":"Moreno","sequence":"first","affiliation":[]},{"given":"Luciane Sussuchi","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Maicon Fernando","family":"Zanon","sequence":"additional","affiliation":[]},{"given":"Murilo","family":"Bonatelli","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1via Escremim","family":"de Paula","sequence":"additional","affiliation":[]},{"given":"Marcus","family":"de Medeiros Matsushita","sequence":"additional","affiliation":[]},{"given":"Gustavo Ramos","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Iara Viana Vidigal","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Fabiano","family":"Saggioro","sequence":"additional","affiliation":[]},{"given":"Luciano","family":"Neder","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o N.","family":"Stavale","sequence":"additional","affiliation":[]},{"given":"Suzana Maria Fleury","family":"Malheiros","sequence":"additional","affiliation":[]},{"given":"Matheus","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Glaucia Noeli Maroso","family":"Hajj","sequence":"additional","affiliation":[]},{"given":"Hernan","family":"Garcia-Rivello","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Christiansen","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o Gil","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Carlos Almeida","family":"Junior","sequence":"additional","affiliation":[]},{"given":"Bruna Minniti","family":"Man\u00e7ano","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-7940","authenticated-orcid":false,"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"3965_CR1","doi-asserted-by":"publisher","unstructured":"Northcott PA, Robinson GW, Kratz CP et al (2019) Medulloblastoma. Nat Rev Dis Primers 5(1):11. https:\/\/doi.org\/10.1038\/s41572-019-0063-6","DOI":"10.1038\/s41572-019-0063-6"},{"key":"3965_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"3965_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.005","journal-title":"Cancer Cell"},{"key":"3965_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/NATURE08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CCH, Porter D et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899\u2013905. https:\/\/doi.org\/10.1038\/NATURE08822","journal-title":"Nature"},{"key":"3965_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/J.CELS.2018.03.003","volume":"6","author":"F Schaub","year":"2018","unstructured":"Schaub F, Dhankani V, Berger A et al (2018) Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas. Cell Syst 6:282-300.e2. https:\/\/doi.org\/10.1016\/J.CELS.2018.03.003","journal-title":"Cell Syst"},{"key":"3965_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1515\/BMC-2013-0026","volume":"4","author":"A Matsui","year":"2013","unstructured":"Matsui A, Ihara T, Suda H et al (2013) Gene amplification: mechanisms and involvement in cancer. Biomol Concepts 4:567\u2013582. https:\/\/doi.org\/10.1515\/BMC-2013-0026","journal-title":"Biomol Concepts"},{"key":"3965_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/GENES8040113","author":"MV Ruiz-P\u00e9rez","year":"2017","unstructured":"Ruiz-P\u00e9rez MV, Henley AB, Arsenian-Henriksson M (2017) The MYCN protein in health and disease. Genes (Basel). https:\/\/doi.org\/10.3390\/GENES8040113","journal-title":"Genes (Basel)"},{"key":"3965_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41571-021-00549-2","volume":"2021","author":"R Dhanasekaran","year":"2021","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD et al (2021) The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol 2021:1\u201314. https:\/\/doi.org\/10.1038\/s41571-021-00549-2","journal-title":"Nat Rev Clin Oncol"},{"key":"3965_CR9","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1158\/0008-5472.CAN-06-1621","volume":"66","author":"BA Hatton","year":"2006","unstructured":"Hatton BA, Knoepfler PS, Kenney AM et al (2006) N-myc is an essential downstream effector of shh signaling during both normal and neoplastic cerebellar growth. Cancer Res 66:8655\u20138661. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1621","journal-title":"Cancer Res"},{"key":"3965_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.694320","author":"S Shrestha","year":"2021","unstructured":"Shrestha S, Morcavallo A, Gorrini C, Chesler L (2021) Biological role of MYCN in medulloblastoma: novel therapeutic opportunities and challenges ahead. Front Oncol. https:\/\/doi.org\/10.3389\/FONC.2021.694320","journal-title":"Front Oncol"},{"key":"3965_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"Pfister S, Remke M, Benner A et al (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27:1627\u20131636. https:\/\/doi.org\/10.1200\/JCO.2008.17.9432","journal-title":"J Clin Oncol"},{"key":"3965_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/gcc.20471","volume":"46","author":"S Pfister","year":"2007","unstructured":"Pfister S, Remke M, Toedt G et al (2007) Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosom Cancer 46:839\u2013851. https:\/\/doi.org\/10.1002\/gcc.20471","journal-title":"Genes Chromosom Cancer"},{"key":"3965_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-81-322-3673-3_16","volume-title":"Chromosom structure and aberrations","author":"AR Shakoori","year":"2017","unstructured":"Shakoori AR (2017) Fluorescence in situ hybridization (FISH) and its applications. In: Bhat TA, Wani AA (eds) Chromosom structure and aberrations. Springer, New Delhi, pp 343\u2013367"},{"key":"3965_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000324698","volume":"134","author":"A Pandita","year":"2011","unstructured":"Pandita A, Bayani J, Paderova J et al (2011) Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification. Cytogenet Genome Res 134:27\u201339. https:\/\/doi.org\/10.1159\/000324698","journal-title":"Cytogenet Genome Res"},{"key":"3965_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.PAS.0000176767.10800.17","volume":"14","author":"M Boensch","year":"2005","unstructured":"Boensch M, Oberthuer A, Fischer M et al (2005) Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q. Diagn Mol Pathol 14:177\u2013182. https:\/\/doi.org\/10.1097\/01.PAS.0000176767.10800.17","journal-title":"Diagn Mol Pathol"},{"key":"3965_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/NBT1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B et al (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26:317\u2013325. https:\/\/doi.org\/10.1038\/NBT1385","journal-title":"Nat Biotechnol"},{"key":"3965_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","volume":"17","author":"HF Tsang","year":"2017","unstructured":"Tsang HF, Xue VW, Koh SP et al (2017) NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics. Expert Rev Mol Diagn 17:95\u2013103. https:\/\/doi.org\/10.1080\/14737159.2017.1268533","journal-title":"Expert Rev Mol Diagn"},{"key":"3965_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/neup.12508","volume":"38","author":"LF Leal","year":"2018","unstructured":"Leal LF, Evangelista AF, de Paula FE et al (2018) Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology 38:475\u2013483. https:\/\/doi.org\/10.1111\/neup.12508","journal-title":"Neuropathology"},{"key":"3965_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jmoldx.2020.04.207","volume":"22","author":"LS da Silva","year":"2020","unstructured":"da Silva LS, Man\u00e7ano BM, de Paula FE et al (2020) Expression of GNAS, TP53, and PTEN improves the patient prognostication in sonic hedgehog (SHH) medulloblastoma subgroup. J Mol Diagnostics 22:957\u2013966. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.04.207","journal-title":"J Mol Diagnostics"},{"key":"3965_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1586\/ERN.12.66","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Dubuc AM, Pfister S, Taylor MD (2012) Molecular subgroups of medulloblastoma. Expert Rev Neurother 12:871. https:\/\/doi.org\/10.1586\/ERN.12.66","journal-title":"Expert Rev Neurother"},{"key":"3965_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.21037\/TLCR-20-740","volume":"10","author":"L Novaes","year":"2021","unstructured":"Novaes L, Sussuchi da Silva L, De Marchi P et al (2021) Simultaneous analysis of Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients. Transl. Lung Cancer Res. 10:292\u2013303. https:\/\/doi.org\/10.21037\/TLCR-20-740","journal-title":"Transl. Lung Cancer Res."},{"key":"3965_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/J.1750-3639.2002.TB00424.X","volume":"12","author":"C Fuller","year":"2002","unstructured":"Fuller C, Perry A (2002) Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol 12:67\u201386. https:\/\/doi.org\/10.1111\/J.1750-3639.2002.TB00424.X","journal-title":"Brain Pathol"},{"key":"3965_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES25081864","author":"NM Chrzanowska","year":"2020","unstructured":"Chrzanowska NM, Kowalewski J, Lewandowska MA (2020) Use of fluorescence in situ hybridization (FISH) in diagnosis and tailored therapies in solid tumors. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES25081864","journal-title":"Molecules"},{"key":"3965_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/1878-0261.12861","volume":"15","author":"C Aguado","year":"2021","unstructured":"Aguado C, Teixido C, Rom\u00e1n R, Reyes R, Gim\u00e9nez-Capit\u00e1n A, Marin E, Cabrera C, Vi\u00f1olas N, Castillo S, Mu\u00f1oz S, Arcocha A, L\u00f3pez-Vilar\u00f3 L, Sullivan I, Aldeguer E, Rodr\u00edguez S, Moya I, Viteri S, Cardona AF, Palmero R, Sainz C, Mesa-Guzm\u00e1n M, Lozano MD, Aguil RN (2021) Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer. Mol Oncol 15:350\u2013363. https:\/\/doi.org\/10.1002\/1878-0261.12861","journal-title":"Mol Oncol"},{"key":"3965_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00401-008-0422-y","volume":"116","author":"A Korshunov","year":"2008","unstructured":"Korshunov A, Benner A, Remke M et al (2008) Accumulation of genomic aberrations during clinical progression of medulloblastoma. Acta Neuropathol 116:383\u2013390. https:\/\/doi.org\/10.1007\/s00401-008-0422-y","journal-title":"Acta Neuropathol"},{"key":"3965_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1200\/JCO.20.01359","volume":"39","author":"R Kumar","year":"2021","unstructured":"Kumar R, Smith KS, Deng M et al (2021) Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma. J Clin Oncol 39:807\u2013821. https:\/\/doi.org\/10.1200\/JCO.20.01359","journal-title":"J Clin Oncol"},{"key":"3965_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014308","author":"MF Roussel","year":"2013","unstructured":"Roussel MF, Robinson GW (2013) Role of MYC in medulloblastoma. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a014308","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3965_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.626751","author":"A Borgenvik","year":"2021","unstructured":"Borgenvik A, \u010can\u010der M, Hutter S et al (2021) Targeting MYCN in molecularly defined malignant brain tumors. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.626751","journal-title":"Front Oncol"},{"key":"3965_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-9904-0_10","volume-title":"Chimeric RNA: methods and protocols","author":"A Goytain","year":"2020","unstructured":"Goytain A, Ng T (2020) NanoString nCounter technology: high-throughput rna validation. In: Li H, Elfman J (eds) Chimeric RNA: methods and protocols. Springer, New York, NY, pp 125\u2013139"},{"key":"3965_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-83132-0","author":"JWP Bracht","year":"2021","unstructured":"Bracht JWP, Gimenez-Capitan A, Huang CY et al (2021) Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platform. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-021-83132-0","journal-title":"Sci Rep"},{"key":"3965_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8393769","author":"KCB Souza","year":"2019","unstructured":"Souza KCB, Evangelista AF, Leal LF et al (2019) Identification of cell-free circulating microRNAs for the detection of early breast cancer and molecular subtyping. J Oncol. https:\/\/doi.org\/10.1155\/2019\/8393769","journal-title":"J Oncol"},{"key":"3965_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6650966","author":"RL Causin","year":"2021","unstructured":"Causin RL, Da Silva LS, Evangelista AF et al (2021) MicroRNA biomarkers of high-grade cervical intraepithelial neoplasia in liquid biopsy. Biomed Res Int. https:\/\/doi.org\/10.1155\/2021\/6650966","journal-title":"Biomed Res Int"},{"key":"3965_CR33","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","volume":"75","author":"MH Veldman-Jones","year":"2015","unstructured":"Veldman-Jones MH, Brant R, Rooney C et al (2015) Evaluating robustness and sensitivity of the nanostring technologies ncounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res 75:2587\u20132593. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0262","journal-title":"Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-03965-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-03965-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-03965-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T08:10:54Z","timestamp":1647850254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-03965-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-03965-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of the present study declare that they have no conflicts of interests<b>.<\/b>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The institutional review board approved this retrospective study from Barretos Cancer Hospital (CAAE: 59979816.6.1001.5437 Number: 4.719.466).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}